Pro‐inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin‐10Vasiliki Koumaki, Helen Α. Papadaki, Athina Damianaki et al.|British Journal of Haematology|2006Cited by 14
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapyEleni Gavriilaki, Ioannis Baltadakis, Ifigeneia Tzannou et al.|Blood Vessels Thrombosis & Hemostasis|2024Cited by 12
Transforming growth factor‐beta1 affects interleukin‐10 production in the bone marrow of patients with chronic idiopathic neutropeniaKaterina Pyrovolaki, Helen Α. Papadaki, Mirjam Klaus et al.|European Journal Of Haematology|2007Cited by 4
P022 Impaired clonogenic and proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromesEmilia Stavroulaki, Helen Α. Papadaki, M. Klaus et al.|Leukemia Research|2007Cited by 0
T-Cell Receptor Vβ Repertoire Analysis in Patients with Chronic Idiopathic Neutropenia: Evidence for Presence of Predominant T-Cell Clones with Possible Pathogenetic Significance.Helen Α. Papadaki, George D. Eliopoulos, Michail Spanoudakis et al.|Blood|2007Cited by 0